Quanterix Corp

NASDAQ:QTRX 4:00:00 PM EDT

6.19

-0.47 (-7.06%)

5:03:09 PM EDT: $6.04 -0.15 (-2.42%)

Market Cap (Intraday)	240.35M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$29.94 Million
Adjusted EPS	-$0.39

See more estimates

10-Day MA	$5.77
50-Day MA	$5.39
200-Day MA	$9.42

See more pivots

Quanterix Corp Stock, NASDAQ:QTRX

Building 1, 900 Middlesex Turnpike, Billerica, Massachusetts 01821

United States of America

Phone: +1.617.301.9400

Number of Employees:

http://www.quanterix.com

Description

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.